Preferred Name |
tafluprost |
|
Synonyms |
Zioptan tafluprost isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate |
|
Definitions |
A prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_66899 |
|
alternative term |
Zioptan tafluprost isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate |
|
bearer_of | ||
charge |
0 |
|
database_cross_reference |
PMID:22654492 PMID:22399693 PMID:22499235 PMID:22606063 Patent:EP1825855 PMID:22275814 PMID:22690824 Drug_Central:4229 PMID:22669351 PMID:22310086 PMID:21423041 PMID:22049909 Reaxys:9668502 KEGG:D06274 Wikipedia:Tafluprost PMID:22583577 PMID:22107041 PMID:21491995 PMID:22695966 CAS:209860-87-7 |
|
formula |
C25H34F2O5 |
|
has functional parent | ||
has role | ||
has_exact_synonym |
isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate |
|
has_obo_namespace |
chebi_ontology |
|
has_related_synonym |
Zioptan tafluprost |
|
has_RxCUI |
1244607 |
|
id |
CHEBI:66899 |
|
in_subset | ||
inchi |
InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1 |
|
inchikey |
WSNODXPBBALQOF-VEJSHDCNSA-N |
|
label |
tafluprost |
|
mass |
452.53130 |
|
monoisotopicmass |
452.23743 |
|
notation |
CHEBI:66899 |
|
prefixIRI |
CHEBI:66899 |
|
prefLabel |
tafluprost |
|
smiles |
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COc1ccccc1 |
|
textual definition |
A prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. |
|
subClassOf |
http://purl.obolibrary.org/obo/CHEBI_37143 |